Trump signs deal with company in effort shift drug manufacturing to U.S.: New York Times

The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times reported late on Monday.